Haemacure Raises $7.8 Million and is Fully Funded Beyond First-Patient...(ooking statements. Such statements based...),Health
Navigation Links
Haemacure Raises $7.8 Million and is Fully Funded Beyond First-Patient-In-Clinic
Date:6/16/2008
ooking statements. Such statements, based as they are on the current expectations of management, inherently involve numerous risks and uncertainties, known and unknown. Some examples of known risks are: the impact of general economic conditions, general conditions in the biotech industry, changes in the regulatory environment in the jurisdictions in which Haemacure does business, stock market volatility, fluctuations in costs, and changes to the competitive environment due to consolidation or otherwise. Consequently, actual future results may differ materially from the anticipated results expressed in the forward-looking statements. Haemacure disclaims any intention or obligation to update these statements.
'/>"/>
| SOURCE HAEMACURE CORPORATION Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Haemacure to Present at the BioInternational Convention - The Global Event for Biotechnology - at the San Diego Convention Centre, California, from June 17 - 20, 2008
2. Haemacure Achieves Major Milestone - Starts Processing Plasma in Its New Fractionation Facility
3. Haemacure Reports on Financing Progress and Second Quarter Results
4. Haemacure to Present at Busines$ Meets Finance on May 20, 2008 at the Montreal Sheraton Centre
5. Haemacure announces webcast of presentation at Rodman & Renshaw 5th Annual Global Healthcare Conference
6. Haemacure financing receives shareholder consent - Series B Warrants are amended
7. Haemacure to Present at the BioFinance 2008 Conference to be held at the Toronto Marriott Eaton Centre, May 6 - 8, 2008
8. Haemacure Discloses Positive Results of a preclinical study of its fibrin sealant in adhesion prevention and opens a new opportunity in a market with a significant unmet medical need
9. Haemacure Reports on its annual general and special meeting of shareholders
10. Media Invitation - Annual General and Special Meeting of Shareholders of Haemacure
11. Haemacure Announces Details of its Annual General and Special Meeting of Shareholders
Post Your Comments:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2[0] Cytiva's one45 Software Rebrands Healthcare Education Administration Products[0] Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events[0] New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation[0] Women's Alcohol Use Tied to Delayed Childbearing
...dard for the prevention and treatment of heart att...icans living with diabetes, the standard dose of a...st future heart attacks. Researchers have recently...n diabetics with coronary artery disease (CAD) tha...
...en with a recent diagnosis of cancer in one breast...// This study was conducted by the Chapel Hill r...international research team found that MRI, or mag...ed cancer in the opposite breast in 30 of 969 wome...
...in Texas in the US almost died of a choking game. ... games.// Levi was found suspended on a rope he h...s neck onto the rope. He wanted to achieve a surgi...t replenished just before the point of unconscious...
...n in a gene linked to dopamine regulation, can lea...aving for alcohol.// The protein alpha synuclein...of dopamine function. SNCA mutations can lead to s...generative disorder Parkinson's disease, which is ...
Other Medicine News:Health News:Aspirin Resistance Is Higher in Diabetics 2Health News:MRI Screening of Other Breast Crucial for Patients Diagnosed With Cancer in One Breast 2Health News:Choking Game, Rage Among US Teens, Evokes Deep Concern 2Health News:Not Parkinson’s Disease Alon 2(Date:8/21/2008)....J. and EMERYVILLE, Calif., Aug. 21 /PRNewswire-Fi... and Onyx Pharmaceuticals, Inc.,(Nasdaq: ONXX ) t...patients,in the STORM Sorafenib as Adjuvant Treatm...lar Carcinoma trial. The randomized, double-blind,...xavar(R) (sorafenib),tablets as adjuvant treatment...
(Date:8/20/2008)...Aug. 20 /PRNewswire-USNewswire/ -- Graduated compr... deep vein thrombosis (DVT) in,hospitalized patien... at,risk for potentially-deadly blood clots, accor...llas., Their findings appear in the September iss...patients are at increased risk for blood clots aft...
(Date:8/19/2008)...M, Pa., Aug. 19 /- Particle Sciences ...uting polymers) development and,pilot production c...,extrusion and injection molding line. The core o...mpounding extruder and Nissei 20T injection,molder...ed polymeric,devices. This addition gives Particle...
(Date:8/18/2008)...WN, Pa., Aug. 18 /PRNewswire-USNewswire/ -- Due to...nfected mosquitoes in,southeastern Pennsylvania, t...county partners will be stepping up efforts this w...- or are most likely to carry -- the virus., Whil...een confirmed,this year (a 27-year-old Montgomery ...
Breaking Medicine Technology:Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 2Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 3Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 4Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer 5Dallas Researchers Find Compression Stockings Improperly Used 2Particle Sciences Expands Its Combination Product Capabilities 2Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 2Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities 3ReBuilder Medical Technologies Inc Increases Manufacturing Space to Meet Demand 3954 1ReBuilder Medical Technologies Inc Increases Manufacturing Space to Meet Demand 3954 2ReBuilder Medical Technologies Inc Increases Manufacturing Space to Meet Demand 3954 3TopSpin Medical Appoints Cindy Setum Ph D Vice President Clinical Affairs 1321 1TopSpin Medical Appoints Cindy Setum Ph D Vice President Clinical Affairs 1321 2MultiVu Video Feed 3A Parents of Kids With Infectious Diseases Sounds Alarm About the Dangers of Pertussis With 22Silence the Sounds of Pertussis 22 3946 1MultiVu Video Feed 3A Parents of Kids With Infectious Diseases Sounds Alarm About the Dangers of Pertussis With 22Silence the Sounds of Pertussis 22 3946 2Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast Ovar 3941 1Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast Ovar 3941 2Society of Gynecologic Oncologists Provides Guidelines for Offering Genetic Risk Assessment to Women With a Personal or Family History of Breast Ovar 3941 3[0] Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer[0] Dallas Researchers Find Compression Stockings Improperly Used[0] Particle Sciences Expands Its Combination Product Capabilities[0] Positive Mosquito Count for West Nile Virus Lead DEP, Southeastern PA Counties to Ramp up Treatment Activities
...esults show risk of heart attack,comparable to two... , June 6, 2007 - A study,of more than 33,000 ty... published today. This study shows that the incide...r a surgery known as,coronary revascularization fo...iabetes treatments. The study results were,release...
...s lead molecule, FP0011, exhibited a differentiate...rance in mid- to,late-stage patients, STRASBOURG, ... a,clinical stage product company specializing in ...s of the nervous system, today,announced that the ...cule glutamate release inhibitor, FP0011, are bein...
Other Medicine Technology:Newly Published Data from Large Study Support Cardiovascular Safety,of Avandia (Rosiglitazone Maleate) 2Newly Published Data from Large Study Support Cardiovascular Safety,of Avandia (Rosiglitazone Maleate) 3Newly Published Data from Large Study Support Cardiovascular Safety,of Avandia (Rosiglitazone Maleate) 4Faust Pharmaceuticals' Phase IIa Results for Parkinson's Disease,Presented at International Congress of Parkinson's Disease and,Movement Disorders 2Faust Pharmaceuticals' Phase IIa Results for Parkinson's Disease,Presented at International Congress of Parkinson's Disease and,Movement Disorders 3Faust Pharmaceuticals' Phase IIa Results for Parkinson's Disease,Presented at International Congress of Parkinson's Disease and,Movement Disorders 4Singe-pull lace design provides easy-on application to provide support and immobilization of the wrist while preserving finger mobility
ManuTrain is an active wrist support that has optional features for increased stabilization.
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
3-Point® Polycentric Hinged Ulnar Deviation Splint uses safe, mild to moderate force to align the hand with ulnar deviation at the MP joints. Dorsal-based splint does not impede grasp or pinch. R
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |